Amgen Inc. Increase (Decrease) in Deferred Income Taxes
Amgen Inc. (AMGN) reported Increase (Decrease) in Deferred Income Taxes of $1.33 billion for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2018-02-13
- Amgen Inc. increase (decrease) in deferred income taxes for fiscal 2017 was $1.33B.
- Amgen Inc. increase (decrease) in deferred income taxes for fiscal 2016 was -$183.00M, a 130.15% decline from fiscal 2015.
- Amgen Inc. increase (decrease) in deferred income taxes for fiscal 2015 was $607.00M, a 462.04% increase from fiscal 2014.
- Amgen Inc. increase (decrease) in deferred income taxes for fiscal 2014 was $108.00M.
| Period end | Increase (Decrease) in Deferred Income Taxes 12 month | Increase (Decrease) in Deferred Income Taxes 12 month as first filed |
|---|---|---|
| 2017-12-31 | $1.33B 10-K · filed 2018-02-13 | |
| 2016-12-31 | -$183.00M 10-K · filed 2018-02-13 | |
| 2015-12-31 | $607.00M 10-K · filed 2018-02-13 | |
| 2014-12-31 | $108.00M 10-K · filed 2017-02-14 | |
| 2013-12-31 | $189.00M 8-K · filed 2016-10-31 | |
| 2012-12-31 | -$28.00M 10-K · filed 2015-02-19 | |
| 2011-12-31 | $328.00M 10-K · filed 2014-02-24 | $399.00M 10-K · filed 2012-02-29 |
| 2010-12-31 | $151.00M 10-K · filed 2013-02-27 | $167.00M 10-K · filed 2011-02-25 |
| 2009-12-31 | -$47.00M 10-K · filed 2012-02-29 | |
| 2008-12-31 | $137.00M 10-K · filed 2011-02-25 | |
| 2007-12-31 | -$56.00M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |